Ophthopedia Update: FDA approves Encelto for macular telangiectasia type 2: Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA approved Encelto, an encapsulated cell therapy, for the treatment of macular telangiectasia type 2, according to a press release…